SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-321491
Filing Date
2021-11-05
Accepted
2021-11-05 15:06:23
Documents
46
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d245901d10q.htm   iXBRL 10-Q 597033
2 EX-31.1 d245901dex311.htm EX-31.1 10343
3 EX-31.2 d245901dex312.htm EX-31.2 10468
4 EX-32.1 d245901dex321.htm EX-32.1 4478
5 EX-32.2 d245901dex322.htm EX-32.2 4479
  Complete submission text file 0001193125-21-321491.txt   3395098

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kvsa-20210930.xsd EX-101.SCH 30717
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kvsa-20210930_cal.xml EX-101.CAL 20210
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kvsa-20210930_def.xml EX-101.DEF 181899
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kvsa-20210930_lab.xml EX-101.LAB 222745
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kvsa-20210930_pre.xml EX-101.PRE 223391
11 EXTRACTED XBRL INSTANCE DOCUMENT d245901d10q_htm.xml XML 465756
Mailing Address 2128 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2128 SAND HILL ROAD MENLO PARK CA 94025 650-376-8500
Khosla Ventures Acquisition Co. (Filer) CIK: 0001841873 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40131 | Film No.: 211384169
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences